Covered recipient · General Payments record
CARLO A GUERRERO
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$2,553.70
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,415.66 | 57 |
| Education | $261.38 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $193.90 | 3 |
| ABBVIE INC. | $155.19 | 9 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $128.37 | 6 |
| AVEO Pharmaceuticals, Inc. | $125.83 | 3 |
| Genmab U.S., Inc. | $102.02 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $90.73 | 2 |
| Daiichi Sankyo Inc. | $82.16 | 3 |
| Merck Sharp & Dohme Corporation | $79.75 | 3 |
| Acerta Pharma LLC | $70.26 | 3 |
| Gilead Sciences, Inc. | $64.71 | 3 |
| EISAI INC. | $63.27 | 3 |
| TerSera Therapeutics LLC | $63.05 | 2 |
| SOBI, INC | $59.03 | 2 |
| GlaxoSmithKline, LLC. | $57.55 | 2 |
| PROGENICS PHARMACEUTICALS, INC. | $52.56 | 2 |
| INTUITIVE SURGICAL, INC. | $48.80 | 1 |
| Regeneron Healthcare Solutions, Inc. | $38.79 | 1 |
| Lilly USA, LLC | $30.86 | 1 |
| TACTILE SYSTEMS TECHNOLOGY INC | $30.62 | 1 |
| Ipsen Biopharmaceuticals, Inc | $29.83 | 1 |
| Rigel Pharmaceuticals, Inc. | $25.65 | 1 |
| Celgene Corporation | $24.49 | 1 |
| PFIZER INC. | $18.33 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.45 | 1 |
| Karyopharm Therapeutics Inc. | $13.76 | 1 |
| Tempus AI, Inc | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (60)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.